Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Resistance mechanisms and fitness of Salmonella Typhimurium and Salmonella Enteritidis mutants evolved under selection with ciprofloxacin in vitro.
Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
parC mutations contribute to high-level fluoroquinolone resistance in E. coli.
parC
Informal genomic surveillance of regional distribution of Salmonella Typhi genotypes and antimicrobial resistance via returning travellers.
Mutations in the quinolone resistance determining region (QRDR) of gyrA and parC are associated with reduced susceptibility to fluoroquinolones.
Conserved collateral antibiotic susceptibility networks in diverse clinical strains of Escherichia coli.
Continuous culture of Escherichia coli, under selective pressure by a novel antimicrobial complex, does not result in development of resistance.
This mutation was observed in the LVX-exposed population and is associated with levofloxacin resistance.
Evolutionary Instability of Collateral Susceptibility Networks in Ciprofloxacin-Resistant Clinical Escherichia coli Strains.
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
parC
Unknown phenotype if G78C occurs alone. Nalidixic acid and ciprofloxacin resistance when associated with gyrA mutations
Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments.
parC
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
Unknown phenotype if G78C occurs alone. Nalidixic acid and ciprofloxacin resistance when associated with gyrA mutations
Topoisomerase IV mutations in quinolone-resistant salmonellae selected in vitro.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research